Scleritis
Methodology & AI Transparency ⓘ
Scleritis Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Recognized across U.S.
- 2 Real-world patient consensus: Diagnostic registry H15.009: Scleritis is managed within Eyes & Vision.
- 3 Typical cash cost range: Workup highlights for Scleritis (H15.009): AREDS2 macular nutrition [Scleritis H15.009].
- 4 Top reported side effects / signs: Key Eyes & Vision biomarkers for Scleritis (H15.009): Intraocular Pressure (IOP) [Scleritis H15.009] & Best-Corrected Visual Acuity in Scleritis (H15.009: & OCT) (Intact retinal nerve fiber & macula (H15.009)).
Ask our AI Specialists anything about Scleritis
What Is Scleritis?
Recognized across U.S. clinical coding as H15.009 (Eyes & Vision), Scleritis is evaluated via AREDS2 macular nutrition [Scleritis H15.009] to align day-to-day symptom relief with long-term physiological stability.
Pathophysiology, Underlying Causes & Clinical Presentation
Biological expression of Scleritis (H15.009, Eyes & Vision) reflects microvascular diabetic/hypertensive retinopathy [Scleritis H15.009]. longitudinal control is benchmarked via Intraocular Pressure (IOP) [Scleritis H15.009].
Common Symptoms & Clinical Signs
- • Presentation of Scleritis (H15.009): gritty burning, foreign-body in Scleritis (H15.009: sensation, reflex tearing,)
- • Secondary Scleritis clinical sign: loss of peripheral in Scleritis (H15.009: side vision)
- • Symptom flares in Scleritis correlating with Intraocular Pressure (IOP) [Scleritis H15.009] deviation outside 10 – 21 mmHg (individualized optic target) (H15.009)
- • Functional eyes & vision impact requiring AREDS2 macular nutrition [Scleritis H15.009] evaluation (H15.009)
Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗
Scleritis Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | H15.009 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Eye Health, Glaucoma & Vision Disorders | NIH MedlinePlus Health Topics |
| Diagnostic / Lab Marker: Intraocular Pressure (IOP) [Scleritis H15.009] | 10 – 21 mmHg (individualized optic target) (H15.009) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Best-Corrected Visual Acuity in Scleritis (H15.009: & OCT) | Intact retinal nerve fiber & macula (H15.009) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: HbA1c & Systemic in Scleritis (H15.009: Blood Pressure) | Microvascular retinal protection (H15.009) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Scleritis
Treatment selection for Scleritis depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Scleritis)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| Can This Approach Help? Inside the Latest Research on Long-Term safety and real-world benefits of Perfluorohexyloctane Ophthalmic PFHO was safe and well tolerated and maintained efficacy for improving signs and symptoms of DED in this year-long study of patients with DED associated with Meibomian gland dysfunction. Cornea • 2024-09-01 • Phase III Randomized Trial | N = 97 | 82/100 | PMID 37921522 ↗ |
Scleritis Patient Community & “People Like Me” Threads
Filter Scleritis community threads and patient logs by age, biological sex, dosage, and treatment duration.